- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06099327
Image-based Remote Monitoring in Cardiac Surgery Patients (FORSEE-3)
Image-based Remote Monitoring in Cardiac Surgery Patients: FORSEE 3 Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Rationale: In hospitals forty percent of unanticipated deaths occur in low-acuity departments. This alarming figure reflects the limited degree to which the cardiorespiratory status of patients is monitored in these departments, due to the obtrusiveness and expense of existing monitoring technologies, as well as the unpractically high clinical workload and costs that deployment of such technologies would entail. We have previously shown that an image-based monitoring technology reliably estimates heart rhythm and breathing rate under controlled conditions.
Objective: This project explores image-based monitoring of the cardiorespiratory status of patients as an innovative unobtrusive method that could eventually aid to reduce workload for the staff and better predict (acute) deterioration or adverse events. The purpose of this study is to evaluate the feasibility, in terms of system fidelity and acceptance, of long-term image-based monitoring in a cardiothoracic ward setting. Secondary objectives are to evaluate the validity of image-based vital signs and circadian rhythms in comparison with reference devices, the discriminative ability of image-based monitoring in the prediction of clinical deterioration and effect of clinical deterioration detected with remote monitoring during hospital admission on long-term patient outcomes.
Study design: Observational study Study population: 100 cardiac surgery patients
Main study parameters/endpoints: Primary endpoints are (1) insight in signal loss due to artifacts and time 'out of scope' of patients, (2) storage and processing solutions to enable conversion of large amounts of image-based data into vital signs and (3) level of acceptance by healthcare staff and patients. Secondary endpoints are performance of image-based vital signs and circadian rhythms in comparison with reference devices and sensitivity and specificity for the prediction of deterioration based on the image-based data. Moreover, potential time gain and predictive value of each image-based parameter will be assessed. Another secondary endpoint is insight in the relation of occurrence of clinical deterioration detected with the image-based monitoring technology during admission and long-term patient outcomes.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Noord-brabant
-
Eindhoven, Noord-brabant, Netherlands, 5623 EJ
- Catharina Ziekenhuis Eindhoven
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥ 18 years
- Willing and able to sign informed consent form
- Patients admitted to the cardio-thoracic ward postoperative after cardiac surgery
- Planned stay on the cardio-thoracic ward at least 48 hours
Exclusion Criteria:
- Pregnant patients
- Inability to provide written informed consent
- Mental disability
- Language barrier
- Inability to wear Healthdot: known severe allergy for the tissue adhesive used in the Healthdot, any skin condition or use of topicals at the area of application of the Healthdot
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Postoperative after cardiac surgery
Patients after cardiac surgery will participate in the trial during their postoperative stay on the cardiothoracic ward.
|
Unobtrusive, vital signs measurements with remote photoplethysmography
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of signal coverage of remote, image-based monitoring in cardiac surgery patients on a general ward
Time Frame: 5-7 days
|
Percentage of signal loss can be due to artifacts as a result movement, lighting conditions, clinical interventions and time 'out of scope' of patients
|
5-7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The validity of remote, image-based heart- and respiration rate in comparison with heart- and respiration rate measured with the Healthdot (smart patch)
Time Frame: 5-7 days
|
Agreement of image-based heart- and respiration rate with healthdot data
|
5-7 days
|
|
The validity of remote, image-based monitoring of circadian rhythms in comparison with the Healthdot (smart patch)
Time Frame: 5-7 days
|
Agreement of image-based carcadian rhythms with healthdot data
|
5-7 days
|
|
Discriminative ability of remote, image-based monitoring in the detection of clinical deterioration
Time Frame: 1 year5-7 days
|
Sensitivity/specificity of image-based data to predict clinical deterioration
|
1 year5-7 days
|
|
Time to detection of clinical deterioration with the image-based monitoring technology vs conventional early warning score (measured via the spot check approach)
Time Frame: 5-7 days
|
Potential time gain as a result of image-based monitoring in detection of clinical deterioration
|
5-7 days
|
|
Predictive value of each image-based parameter in the detection of postoperative complications
Time Frame: 5-7 days
|
Added value of each image-based parameters in the detection of clinical deterioration
|
5-7 days
|
|
Effect of clinical deterioration detected with image-based, remote monitoring during hospital admission on long term patient outcomes (mortality, complications)
Time Frame: 2 years
|
Association of occurence of postoperative complications with long term outcomes
|
2 years
|
|
Invasion of privacy of image-based remote monitoring, experienced by patients and healthcare staff, presented on a likert scale (1 means no invasion of privacy at all and 5 serious invasion of privacy)
Time Frame: 5-7 days
|
Invasion of privacy will be assessed with a questionnaire with a likert scale (1-5), 1 means no invasion of privacy at all and 5 serious invasion of privacy.
|
5-7 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lukas Dekker, Prof. dr., Catharina Ziekenhuis Eindhoven
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CZE-2023.28
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vital Signs
-
Nuralogix CorporationUniversity Health Network, Toronto; Hamilton Health Sciences CorporationNot yet recruiting
-
Oxehealth LimitedCentral and North West London NHS Foundation TrustCompleted
-
Dr. Behcet Uz Children's HospitalCompleted
-
Ain Shams UniversityCompleted
-
Rigshospitalet, DenmarkCompleted
-
LifeWatch Services, Inc.Completed
-
Tampere University HospitalTampere UniversityCompleted
-
Xim LimitedCompletedVital SignsUnited Kingdom
-
LifeWatch Services, Inc.Completed
Clinical Trials on Image-based vital sign monitoring
-
University of AlbertaNot yet recruiting
-
The University of Texas Health Science Center,...Masimo CorporationNot yet recruiting
-
Universitätsklinikum Hamburg-EppendorfRecruitingVital Sign Monitoring | Non-cardiac Surgery | Anesthesiology | Post Operative Complications | RCTGermany
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecruitingPreterm Infant | Low; Birthweight, Extremely (999 Grams or Less) | Infant, NewbornUnited Kingdom
-
Bispebjerg HospitalActive, not recruitingRemote Monitoring | Vital Signs Monitoring | Hospital at Home | Continuous MonitoringDenmark
-
Northwell HealthNew York State Department of HealthRecruiting
-
Massachusetts General HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingPregnancy Complications | Maternal Death During ChildbirthUganda
-
Guilherme Sant'Anna, MDLuzerner Kantonsspital; Hospital Universitário da Universidade Estadual de... and other collaboratorsRecruitingInfant, Newborn, Diseases | Sudden Unexplained Infant Death | Infant Death | Pregnancy Related | Infant Conditions | Infant ALL | Parents | Newborn Morbidity | Newborn; Vitality | Birth Asphyxia | Delivery Complication | ECG Electrode Site Reaction | Infant Apnea | Newborn Asphyxia | Delivery Problem for Fetus | Apnea of... and other conditionsCanada, Brazil, Italy, Switzerland
-
The Cleveland ClinicCompletedPostoperative ComplicationsUnited States
-
KK Women's and Children's HospitalRenew GroupActive, not recruitingHeart Rate | Respiratory Rate | Vital SignSingapore